With help from Dutch Bros., MDA is fighting to end ALS
Thanks in part to Dutch Bros. generous support, MDA is currently funding 38 active ALS grants, with a total funding commitment of $9.6 million.
Thanks in part to Dutch Bros. generous support, MDA is currently funding 38 active ALS grants, with a total funding commitment of $9.6 million.
Lyndsay Murray of the University of Edinburgh in Scotland was awarded an MDA research grant to investigate how therapies work at different stages of SMA
Researchers are looking for people with CMT to participate in a phase 2 clinical trial, sponsored by Acceleron Pharma.
Learn more about researcher Johanna Hamel’s clinical research training fellowship.
Joe Akmakjian shares highlights from his interview with MDA grant recipient Mattia Quattrocelli.
Johanna Hamel, M.D., received an MDA co-sponsored Clinical Research Training Fellowship for her work studying myotonic dystrophy (DM).
Parents of young boys with DMD, as well as parents of age-matched non-affected boys, are being sought to participate in an online observational study.
Octapharma USA’s investigational drug IVIG (brand name Octagam) to treat dermatomyositis, has received FDA orphan drug designation.
The investigational drug AMO-02 (tideglusib) has received FDA fast track designation for the treatment of DM1.
Dr. Charles Emerson was awarded an MDA research grant to study FSHD.